Author Topic: (Abst.) COVID-19 in a patient w/MS treated w/Tysabri: Blockade of integrins protective?  (Read 49 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest


Investigators are working on the idea that Tysabri may be helpful in treating COVID-19.See also the May 12 thread under this heading--it seems to be a different case.


From PubMed (June 13, 2020)--"Covid-19 in a patient with multiple sclerosis treated with natalizumab: May the blockage of integrins have a protective role?"


https://pubmed.ncbi.nlm.nih.gov/32531754/
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
2 Replies
125 Views
Last post October 17, 2019, 09:09:54 pm
by agate
0 Replies
59 Views
Last post May 15, 2020, 12:36:31 pm
by agate
0 Replies
58 Views
Last post August 07, 2020, 02:51:51 pm
by agate
0 Replies
49 Views
Last post August 22, 2020, 05:33:55 pm
by agate
0 Replies
55 Views
Last post August 29, 2020, 03:19:57 pm
by agate